🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our new work in nature - check it out! We developed a way to image the immune system using PET. Our goal? To peer into the body and see where inflammation is hiding 🧐 Many thanks to Ali Salehi Farid, Mohammad Rashidian & the whole team 🙏🙏 nature.com/articles/s4158…

More than 40 percent of #postdocs leave academia. Those who landed a coveted faculty position were more likely to have had a highly cited paper, changed their research topic between their #PhD and postdoc, or moved abroad after receiving their doctorate. pnas.org/doi/10.1073/pn…

CD45-PET is a robust, non-invasive tool for imaging inflammation | Nature ⁦Parker Institute for Cancer Immunotherapy⁩ nature.com/articles/s4158…

Top 5 advances in medicine this week (🧵) 1. A tool to image inflammation Inflammation happens in a range of diseases - autoimmunity, aging, cancer - but we lack a tool to visualise it This study used CD45, which is expressed by all - and only - immune cells, as a marker of

That airplane was taking figure skaters, coaches and their families home from a national training camp. It was full of talented young people just beginning their lives, moms and dads, brothers and sisters. My heart is sick as a mother. May God bless, comfort, and keep the

🚨Excited to share our latest work, now out in Nature Biotechnology ! We introduce SEED-Selection, a powerful method that enables high-efficiency enrichment of T cells edited at multiple loci in a single step 🧵👇 🔗 nature.com/articles/s4158…

The 4th Transatlantic Exchanges between Gustave Roussy and Dana-Farber is set for March 19th. Use QR code below to register virtually! Topic: Radioligand therapy in Oncology Fabrice Barlesi Fabrice Barlesi Heather Jacene Kevin Haigis Lab #Fizazi Ellen Berlin✌🏼🦞✡️🌍☀️⚾️🇺🇸 Medscape Servier Mohammad Rashidian

Another Dana-Farber superstar Mohammad Rashidian discussing his innovative work targeting CD45 as a diagnostic and therapeutic target. Very promising for inflammatory disorders and hematological malignancies! Check his CD45-PET nature paper here: rdcu.be/d688j

On Lynch Syndrome Awareness Day, we’re spotlighting research on a vaccine designed to train the immune system to detect and eliminate cancer cells before they form. Learn how this could transform cancer prevention for Lynch syndrome patients: bit.ly/3XwfAa6

We examined the present and future of AI and translational cancer research for Cancer Cell - check out superstar Josephine Yates below for more on this perspective! Dana-Farber News

CD45-PET imaging gives a panoramic view of in vivo immune activity bit.ly/3RNlbFY

CD45-PET is a game-changer for basic and translational immunology—finally letting us track immune dynamics in vivo. Its clinical potential is huge: from diagnosing immune-driven diseases to monitoring therapy response in real time. Excited to help unlock more of its potential!

Watch our exclusive discussion from #iwCART25 with experts L. Elizabeth Budde, M.D., Ph.D., Mohammad Rashidian, Michael Jain, & Marco Ruella to hear about potential strategies being explored to improve efficacy & minimize toxicity of #CARTCell therapy 💉🩸: 🎥 ow.ly/tHNc50VOtvt #ImmunoOnc

Just got notice the NIH grant supporting top trainees in my lab working on epigenetic reprogramming to cure diseases that needlessly disable and kill millions of americans a year has been terminated. Pointless and cruel

Without its international students, Harvard is not Harvard. hrvd.me/IntStudents25t